Navigation Links
Americans Optimistic About the War on Cancer

natural process by which damaged or unwanted cells die and are cleared from the body.

According to the survey, Americans also recognize that progress in the fight against cancer is already being made. Four out of five (83%) believe the chances of surviving cancer are better now than they were ten years ago. And almost half (48%) think the chances of survival are "much better" today.

"Abbott has several promising anti-cancer compounds in its oncology pipeline that may prove to be very effective in the fight against cancer," said Stephen Fesik, Ph.D., divisional vice president, Cancer Research, Abbott. "We are committed to exploring new cutting-edge therapies that may enable patients to live longer and healthier lives. Our strategy involves targeting the differences between cancer cells and normal cells and taking away the key fundamental needs of cancer."

More than 1,000 respondents participated in the telephone survey sponsored by Abbott. The goal of the survey was to assess Americans' perceptions of cancer research and their outlook regarding new treatments. Opinion Research Corporation conducted the research.


'"/>




Page: 1 2

Related medicine news :

1. Poll Finds Many Americans Misinformed About Cancer
2. Poll Finds Many Americans Misinformed About Cancer
3. Hypertension Drug of Choice for African Americans
4. 38 million Americans including 14 million children left to combat hunger
5. Americans Consume Far Too Much Salt and Sodium
6. Americans Growing Out Of Shape
7. Rise in Stress among Americans
8. Home Remedies More Used By Blacks And Native Americans
9. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
10. Aspirin, Not Used By African Americans And Diabetics To Prevent Heat Problems
11. Americans Not Interested In Choosing Sex Of Child: Survey
Post Your Comments:
(Date:1/7/2009)...with hypoxia remains unclear , , WEDNESDAY...most elevated natural laboratory, Mount Everest, B... medical rules about the amount of oxygen needed b...le can tolerate extremely low levels of oxygen, mu...Grocott, from University College London and lead a...
(Date:1/7/2009)...ation,(NYSE: SYK ) announced today that it will ..., , January 14, 2009 -- 10:00 a.m. Paci...hcare Conference, San Francisco, Califo...s presentation will be available on,Stryker,s webs...e. The,presentation for the J.P. Morgan Health Ca...
(Date:1/7/2009)...tly awarded two core faculty members of the Johns ... will allow Drs. Gail Geller and Cynda Hylton Rush...ssionals face while caring for children and famili...ases (LTNMD). , The concept for this latest LTNMD...eartSongs Project funded by the Stavros Niarchos F...
(Date:1/7/2009)...tory Plans for Cutting-Edge Technology at National... , WASHINGTON, Jan. 7 Nanotechnology was incorpor...ods last year. By 2014, the market will grow to $2...bled drugs and therapeutics will be sold--up from ... project that nanotechnology will be incorporated ...
Breaking Medicine News(10 mins):Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3Health News:Stryker To Present at Investor Conference 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 2Health News:Study to explore ethical challenges health professionals face while caring for children with LTNMDs 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 2Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 3Health News:Food and Drug Law Institute Sponsors Major Conference on Nanotechnology Law, Regulation and Policy 4
...vealed that middle-aged to older U.S. residents ap...an their English counterparts. // The results of t... JAMA. The United States spends considerably mor...74) than the United Kingdom ($2,164). However, whe...
... Center has compelled nurses who did not get their...Nurses Association union has filed a complaint wit...lations Board (NLRB). This complaint has been the...n the hospital, its nurses and the union. The NLRB...
...t lack of insurance means worse care when it comes...er diseases early, even for the relatively well of... a primary care internist in the Robert Wood Johns...niversity, explained that lacking in health insura...
...ormer commissioner of the Food and Drug Administra... following accusations of financial improprieties....t a grand jury had begun a criminal investigation ... have told a federal magistrate, in a telephone he...
Other Medicine News:Health News:Americans-Not So Healthy After All 2Health News:Lack Of Insurance Means Worse Care For Uninsured 2Health News:Lack Of Insurance Means Worse Care For Uninsured 3
(Date:1/5/2009)... BETHESDA, Md., Jan. 5 /PRNewswire-FirstCall/ -...utical company developing novel, proprietary,anti...nd autoimmune diseases,provides an outlook on ke... Micromet intends to provide an update on its rese...ents: , -- April 12 to 16, 2009: Update on ...
(Date:12/29/2008)...BETHESDA, Md., Dec. 29 ...an Research Protection was announced today by Dr. ... Health Improvement Institute. , , The winner ... M.D. Anderson Cancer Center -- for its best pr...This program provides for 1) enhanced human subjec...
(Date:12/17/2008)...ificant milestone met in development and validatio... ASHLAND, Mass., Dec. 17 MatTek C...ic Advisory Committee (ESAC) endorsed the scientif...n Test (SIT) at its November meeting. ESAC conclu...ccuracy and reliability for the prediction of skin...
(Date:12/17/2008)...FRANCISCO, Dec. 17 Mediv...t it has completed patient enrollment in a,Phase ... novel androgen,receptor antagonist, in castratio... will seek approval from the U.S. Food and Drug Ad... trials next year. , The open-label, U.S. P...
Breaking Medicine Technology:Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2EpiDerm's Skin Irritation Test Fully Validated in European Union 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4At risk for peripheral arterial disease 3F Simple quiz provides key so you can circulate better 4708 1At risk for peripheral arterial disease 3F Simple quiz provides key so you can circulate better 4708 2At risk for peripheral arterial disease 3F Simple quiz provides key so you can circulate better 4708 3Air Quality Action Day Forecast Thursday in All Regions 26056 1Air Quality Action Day Forecast Thursday in All Regions 26056 2New nano device detects immune system cell signaling 26053 1New nano device detects immune system cell signaling 26053 2New nano device detects immune system cell signaling 26053 3New nano device detects immune system cell signaling 26053 4New nano device detects immune system cell signaling 26053 5Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 1Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 2Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 3Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 4Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 5Produce for Kids 28R 29 and PBS KIDS 28R 29 Partner for a Second Year with Nationwide School Based Healthy Eating Campaign 26050 6
...lished today in the Journal of the National Cancer...d, 2 May 2007 - In a study published today in,the ...vative cancer,drug MabThera was shown to improve o...ss of the chemotherapy regimen used.1 The,review f... seen for,the first time in patients with mantle c...
... May 1, 2007—The drug levosimendan did not i...art failure when,compared with a more widely-used ...g to a study in the May 2 issue of, JAMA . , Acute...ailure,characterized by inability of the heart to ...mon cause of hospitalization worldwide,but approp...
Other Medicine Technology:MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 2MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 3MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 4Drug for Treatment of Heart Failure Does Not Improve Survival,Compared to More Widely-used Medication 2
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: